Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/8690

1,2-Dihydro-2,2,4-trimethylquinoline (monomer): Target Organs and Levels of Evidence for TR-456

Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CASRN 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Initiation/Promotion (Dermal Study) in Female Sencar Mice


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
1,2-Dihydro-2,2,4-trimethylquinoline (monomer)
147-47-7
06/20/1995 Topical Application
RATS: 0, 36, 60, OR 100 MG/KG MICE: 0, 3.6, 6.0, OR 10.0 MG/KG
T.S.I. Mason Laboratories, Inc.

Levels of Evidence

Type Organ/Tissue (Lesion)
Note
  • 1 YEAR DERMAL INITIATION/PROMOTION STUDY IN FEMALE SENCAR MICE. THERE WAS NO EVIDENCE OF INITIATING OR PROMOTING ACTIVITY.


Chemical (Study Title)
CASRN
Peer Review Date Primary Uses Route/Exposure Levels Study Laboratory
1,2-Dihydro-2,2,4-trimethylquinoline (monomer)
147-47-7
06/20/1995 Monomer polymerized for use as a rubber and latex antioxidant. Topical Application
RATS: 0, 60, OR 100 MG/KG MICE: 0, 6, OR 10 MG/KG (CORE)
T.S.I. Mason Laboratories, Inc.

Levels of Evidence

Male Rats: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA (SINGLE SECTIONS) 1/50 7/50 10/50 7/50 (STEP SECTIONS) 6/50 5/50 6/50 8/50 (COMBINED) 7/50 11/50 14/50 14/50; CARCINOMA (SINGLE SECTIONS) 0/50 1/50 0/50 0/50 (STEP SECTIONS) 0/50 1/50 0/50 0/50 (COMBINED) 0/50 1/50 0/50 0/50; ADENOMA OR CARCINOMA COMBINED (SINGLE SECTIONS) 1/50 8/50 10/50 7/50 (STEP SECTIONS) 6/50 6/50 6/50 8/50 (COMBINED) 7/50 12/50 14/50 14/50
Non-Neoplastic Lesions
  • SKIN: ACANTHOSIS
Female Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • SKIN: ACANTHOSIS; HYPERKERATOSIS
Male Mice: No Evidence
Female Mice: No Evidence